drugset / Trial / NCT00735410

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009

NCT00735410

Phase 3 Completed 134 enrolled Novartis Vaccines
RandomizedSingle-groupOpen-labelPrevention

Summary

Annual trial for registration influenza vaccine with the strain composition for season 2008/2009

Timeline

Start
2008-06
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Quadrivalent influenza vaccine Vaccine

Indications

No indication recorded.